Application of PET/CT to the molecularly-targeted therapy for thyroid cancer patients
Not Applicable
- Conditions
- thyroid cancer
- Registration Number
- JPRN-UMIN000024766
- Lead Sponsor
- Tokyo Women's Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1. Pregnant women and women suspected of being pregnant 2. Patients with an incurable malignancy other than thyroid cancer 3. Patients present hyperglycemia (>200 mg/dL) 4. Patients present a poor image quality of PET/CT 5. Patients judged as inadequate trial subjects
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method FDG or MET uptake at before and 1 month after the initiation of molecularly-targeted therapy
- Secondary Outcome Measures
Name Time Method